<code id='2C5DB3022E'></code><style id='2C5DB3022E'></style>
    • <acronym id='2C5DB3022E'></acronym>
      <center id='2C5DB3022E'><center id='2C5DB3022E'><tfoot id='2C5DB3022E'></tfoot></center><abbr id='2C5DB3022E'><dir id='2C5DB3022E'><tfoot id='2C5DB3022E'></tfoot><noframes id='2C5DB3022E'>

    • <optgroup id='2C5DB3022E'><strike id='2C5DB3022E'><sup id='2C5DB3022E'></sup></strike><code id='2C5DB3022E'></code></optgroup>
        1. <b id='2C5DB3022E'><label id='2C5DB3022E'><select id='2C5DB3022E'><dt id='2C5DB3022E'><span id='2C5DB3022E'></span></dt></select></label></b><u id='2C5DB3022E'></u>
          <i id='2C5DB3022E'><strike id='2C5DB3022E'><tt id='2C5DB3022E'><pre id='2C5DB3022E'></pre></tt></strike></i>

          Home / fashion / leisure time

          leisure time


          leisure time

          author:explore    Page View:7783
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In